NBIX
NEUROCRINE BIOSCIENCES INC · Healthcare · Market cap $14.4B
Insiders sold $7.9M net in the last 90 days ·6 sellers, 0 buyers· 11 of 11 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 15, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$77.9M
reported sales (SEC code S)
Unique Insiders
15
in the rolling window
Latest filing
Sep 15, 2026
Boyer David W.
NEUROCRINE BIOSCIENCES INC (NBIX) has 70 SEC Form 4 filings (199 transaction rows) in the rolling window, disclosed by 15 distinct insiders. Most recent filing: Sep 15, 2026.
Inside the rolling window, 15 insiders at NEUROCRINE BIOSCIENCES INC reported no open-market purchases and 30 open-market sales totaling $77.9M. The most active filer is Director Norwalk Leslie V with 5 filings. Insiders have net sold $63.3M over the trailing 6 months. The most recent open-market filing is a sale of 826 shares by Chief Corp. Affairs Officer Boyer David W., dated Sep 14, 2026, worth $130K.
- Industry:Biotechnology
- CEO:Kyle W. Gano
- Employees:2,500
- HQ:San Diego, CA, US
- IPO:1996-05-23
| Source | |||||||
|---|---|---|---|---|---|---|---|
Boyer David W.First in 4 months | Chief Corp. Affairs Officer | Sale | 826 | $130K | Sep 15 | -5.8% | SEC ↗ |
ABERNETHY MATTFirst filing | Chief Financial Officer | Sale | 2,311 | $363K | Sep 15 | -5.8% | SEC ↗ |
BENEVICH ERICFirst in 9 months | Chief Commercial Officer | Sale | 2,154 | $333K | Sep 11 | -9.5% | SEC ↗ |
| Director | Sale | 1,250 | $228K | Jul 30 | -23.8% | SEC ↗ | |
| Chief Regulatory Officer | Sale | 4,367 | $791K | Jul 13 | -18.8% | SEC ↗ | |
| Chief Legal Officer | Sale | 10,000 | $1.8M | Jul 13 | -18.8% | SEC ↗ | |
| Chief Regulatory Officer | Sale | 3,401 | $607K | Jul 9 | -21.7% | SEC ↗ | |
| Chief Regulatory Officer | Sale | 2,737 | $489K | Jul 9 | -21.7% | SEC ↗ | |
| Chief Regulatory Officer | Sale | 8,433 | $1.5M | Jul 9 | -21.7% | SEC ↗ | |
Lippoldt DarinFirst in 7 months | Chief Legal Officer | Sale | 200 | $34K | Jun 30 | -16.2% | SEC ↗ |
Lippoldt DarinFirst in 7 months | Chief Legal Officer | Sale | 9,800 | $1.7M | Jun 30 | — | SEC ↗ |
SHERWIN STEPHEN AFirst filing | Director | Sale | 25,000 | $4.1M | Jun 9 | — | SEC ↗ |
| Director | Sale | 1,250 | $210K | Jun 8 | — | SEC ↗ | |
Cooke JulieFirst filing | Chief Human Resources Officer | Sale | 36,937 | $5.8M | Jun 4 | — | SEC ↗ |
Delaet IngridFirst filing | Chief Regulatory Officer | Sale | 2,261 | $354K | Jun 2 | — | SEC ↗ |
| Chief Scientific Officer | Sale | 11,000 | $1.8M | Jun 2 | — | SEC ↗ | |
Onyia JudeFirst filing | Chief Scientific Officer | Sale | 11,000 | $1.7M | May 29 | — | SEC ↗ |
Boyer David W.First filing | Chief Corp. Affairs Officer | Sale | 3,888 | $609K | May 28 | — | SEC ↗ |
GORMAN KEVIN CHARLESFirst filing | Director | Sale | 245,088 | $37.8M | May 21 | — | SEC ↗ |
POPS RICHARD FFirst filing | Director | Sale | 15,000 | $2.4M | May 18 | — | SEC ↗ |
Norwalk Leslie VFirst in 4 months | Director | Sale | 3,810 | $591K | May 14 | — | SEC ↗ |
| Chief Executive Officer | Sale | 36,400 | $4.8M | Jan 20 | — | SEC ↗ | |
| Director | Sale | 5,000 | $761K | Dec 17 | — | SEC ↗ | |
| Director | Sale | 1,190 | $185K | Dec 17 | — | SEC ↗ | |
Lippoldt DarinFirst filing | Chief Legal Officer | Sale | 4,376 | $699K | Dec 10 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading NBIX 24 all-time
- RRep. Lisa C. McClainPurchase$1,001 - $15,0002025-06-11
- RRep. Lisa C. McClainPurchase$1,001 - $15,0002025-06-11
- RRep. Lisa C. McClainOther$1,001 - $15,0002025-06-17
- RRep. Michael T. McCaulSale$15,001 - $50,0002024-11-19
- RRep. Michael T. McCaulSale$1,001 - $15,0002024-08-26
- RRep. Michael T. McCaulSale$50,001 - $100,0002023-10-27
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does NBIX have?
NEUROCRINE BIOSCIENCES INC (NBIX) has 70 SEC Form 4 filings (199 transaction rows) in the rolling 365-day window, disclosed by 15 distinct insiders. Most recent filing: Sep 15, 2026.
When was the most recent SEC Form 4 filing for NBIX?
The most recent Form 4 filing for NBIX on Tracefour is dated Sep 15, 2026.
Who is the most active insider at NBIX?
The most active SEC Form 4 filer at NBIX in the rolling window is Director Norwalk Leslie V, with 5 filings.
What is the net insider flow at NBIX over the last 6 months?
Over the trailing 180 days, insiders at NBIX have net sold $63.3M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at NBIX in the current window?
Inside the rolling window, insiders at NBIX bought $0 and sold $77.9M based on SEC Form 4 filings.
Can I get alerts for NBIX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at NEUROCRINE BIOSCIENCES INC (NBIX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
NEUROCRINE BIOSCIENCES INC is in the Healthcare sector.